Mark Ranalli
Pediatric Hematology-Oncology · Columbus, OHNPI 1205824331
Payments from drug & device makers
What this record shows
That places this record below the midpoint for pediatric hematology-oncology clinicians in OH, where the typical reported total is $705.
No general payments reported
No drug or device maker reported general payments to this provider for 2019–2025. That is a common and unremarkable result.
$3,138,567in research payments, 2019–2025
Across 244 payments — averaging $12,863 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Incyte Corporation$1.9M
- Jazz Pharmaceuticals Inc.$608K
- E.r. Squibb & Sons, L.L.C.$308K
- Pfizer$127K
- Merck$126K
- AbbVie$38K
- plus $33K from 3 others
How this compares
$0 in reported general payments places this provider in the 5th percentile of 143 pediatric hematology-oncology providers in Ohio.
Other pediatric hematology-oncology in Columbus
- Amy DunnColumbus$129K
- Bryce KerlinColumbus$123K
- Anthony VillellaColumbus$66K
- Sarah ObrienColumbus$30K
- Timothy CripeColumbus$26K
- Dean LeeColumbus$20K
- Ryuma TanakaColumbus$16K
- Nilay ShahColumbus$16K
- Melissa RoseColumbus$15K
- Rolla Abu ArjaColumbus$14K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.